Clinical trials
Phase 3 Multiple Myeloma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
177 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 7 |
| 2001 | 1 |
| 2002 | 5 |
| 2003 | 8 |
| 2004 | 7 |
| 2005 | 7 |
| 2006 | 5 |
| 2007 | 3 |
| 2008 | 10 |
| 2009 | 3 |
| 2010 | 8 |
| 2011 | 8 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 5 |
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 6 |
| 2018 | 3 |
| 2019 | 7 |
| 2020 | 7 |
| 2021 | 4 |
| 2022 | 9 |
| 2023 | 7 |
| 2024 | 8 |
| 2025 | 1 |
| 2026 | 13 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 99 |
| Active, not recruiting | 33 |
| Recruiting | 25 |
| Terminated | 15 |
| Not yet recruiting | 2 |
| Withdrawn | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 18 |
| University of Arkansas | 11 |
| Celgene | 9 |
| Amgen | 7 |
| Fred Hutchinson Cancer Center | 7 |
| National Cancer Institute (NCI) | 7 |
| Alliance for Clinical Trials in Oncology | 6 |
| Bristol-Myers Squibb | 6 |
| AbbVie | 5 |
| GlaxoSmithKline | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 177 |
| Neoplasms, Plasma Cell | 37 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 28 |
| Lymphoma, Non-Hodgkin | 27 |
| Hodgkin Disease | 26 |
| Recurrence | 25 |
| Lymphoma, Large B-Cell, Diffuse | 23 |
| Lymphoma, Mantle-Cell | 23 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 22 |
| Lymphoma, Follicular | 21 |
Trials
Showing 1 to 25 of 177. Each trial links to its page on Pharma Observatory.
77 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.